Table 2.

Transfusions decrease CBF and OEF without altering CMRO2

Median (25th-75th IQR)P
PretransfusionPosttransfusionΔ
CBF, mL/100 g per min     
 Whole brain 88.0 (73.4-110.8) 82.4 (70.9-99.6) −6.5 (1.2 to −18.7) .005* 
 Gray matter 108.7 (90.5-129.4) 99.5 (84.4-122.4) −11.9 (−4.3 to −23.6) .01* 
 White matter 59.5 (48.0-72.5) 55.7 (48.8-60.7) −2.5 (0.3 to −11.5) .03* 
OEF, %     
 Whole brain 34.4 (32.1-38.5) 31.2 (29.6-33.8) −2.0 (−1.0 to −5.1) <.0001* 
 Gray matter 35.1 (32.9-37.4) 32.5 (30.6-33.9) −2.3 (−0.4 to −4.5) <.0001* 
 White matter 33.5 (31.1-38.9) 30.6 (28.8-33.8) −2.5 (−0.9 to −5.8) <.0001* 
CMRO2, mL/100 g per min     
 Whole brain 3.2 (2.7-3.6) 3.2 (2.5-3.7) −0.1 (0.1 to −0.8) .07 
 Gray matter 4.0 (3.3-4.3) 4.0 (3.1-4.4) −0.1 (0.0 to −0.6) .08 
 White matter 2.4 (1.9-3.0) 2.3 (1.9-2.5) −0.1 (0.1 to −0.5) .10 
Median (25th-75th IQR)P
PretransfusionPosttransfusionΔ
CBF, mL/100 g per min     
 Whole brain 88.0 (73.4-110.8) 82.4 (70.9-99.6) −6.5 (1.2 to −18.7) .005* 
 Gray matter 108.7 (90.5-129.4) 99.5 (84.4-122.4) −11.9 (−4.3 to −23.6) .01* 
 White matter 59.5 (48.0-72.5) 55.7 (48.8-60.7) −2.5 (0.3 to −11.5) .03* 
OEF, %     
 Whole brain 34.4 (32.1-38.5) 31.2 (29.6-33.8) −2.0 (−1.0 to −5.1) <.0001* 
 Gray matter 35.1 (32.9-37.4) 32.5 (30.6-33.9) −2.3 (−0.4 to −4.5) <.0001* 
 White matter 33.5 (31.1-38.9) 30.6 (28.8-33.8) −2.5 (−0.9 to −5.8) <.0001* 
CMRO2, mL/100 g per min     
 Whole brain 3.2 (2.7-3.6) 3.2 (2.5-3.7) −0.1 (0.1 to −0.8) .07 
 Gray matter 4.0 (3.3-4.3) 4.0 (3.1-4.4) −0.1 (0.0 to −0.6) .08 
 White matter 2.4 (1.9-3.0) 2.3 (1.9-2.5) −0.1 (0.1 to −0.5) .10 

Wilcoxon signed-rank test was used for all comparisons. Bold P values indicate statistical significance.

*

P values remaining significant after Benjamani-Hochberg procedure for multiple-comparison adjustment.

or Create an Account

Close Modal
Close Modal